1. DEVELOPMENT OF NOVEL, NON‐TOXIC RIFAMYCINS THAT REVERSE DRUG RESISTANCE IN DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL). (June 2017) Authors: Maxwell, S.A.; Wallis, D.; Zhou, N.; Baker, D.; Mousavi‐Fard, S.; Loesch, K.; Galaviz, S.; Sun, Q.; Threadgill, D.M.; Rojas, C.M.; O'Brien, M.; Clubb, F.J.; Ioerger, T.; DeJesus, M.; Dong, W.; Seemann, G.; Fossum, T.; Sacchettini, J.C. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗